PsyBio Therapeutics Corp.
PSYBF
$0.00
$0.000.00%
OTC PK
| 06/30/2023 | 03/31/2023 | 12/31/2022 | 09/30/2022 | 06/30/2022 | |
|---|---|---|---|---|---|
| Net Income | 195.61% | 13.82% | -2.14% | 35.85% | 9.34% |
| Total Depreciation and Amortization | -100.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -515.00% | 3,234.33% | -92.19% | -59.85% | -43.73% |
| Change in Net Operating Assets | -208.17% | -73.38% | 710.31% | 175.93% | -29.98% |
| Cash from Operations | -1.74% | -114.16% | 76.55% | 45.73% | -3.61% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -100.00% | -37.86% | 6.94% |
| Cash from Investing | -- | -- | -100.00% | -37.86% | 6.94% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | 50.00% | 33.33% | 0.00% |
| Issuance of Common Stock | -16.84% | 87.98% | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | 100.00% | -1,455.10% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 9,918.75% | -- | -- | -- | -- |
| Cash from Financing | 92.13% | 103.78% | 620.80% | 77.96% | -170.22% |
| Foreign Exchange rate Adjustments | 200.00% | -600.00% | -120.00% | 150.00% | 300.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 13.32% | -179.06% | -119.18% | 344.98% | -213.21% |